558 related articles for article (PubMed ID: 437169)
1. Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
Frank DW; Kirton KT; Murchison TE; Quinlan WJ; Coleman ME; Gilbertson TJ; Feenstra ES; Kimball FA
Fertil Steril; 1979 Mar; 31(3):340-6. PubMed ID: 437169
[TBL] [Abstract][Full Text] [Related]
2. Grwoth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate.
Concannon P; Altszuler N; Hampshire J; Butler WR; Hansel W
Endocrinology; 1980 Apr; 106(4):1173-7. PubMed ID: 6444575
[TBL] [Abstract][Full Text] [Related]
3. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice.
Yanai R; Nagasawa H
Int J Cancer; 1976 Sep; 18(3):317-21. PubMed ID: 986372
[TBL] [Abstract][Full Text] [Related]
4. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
5. Serum follicle-stimulating hormone, luteinizing hormone and progesterone concentrations in pseudopregnant rats treated with medroxyprogesterone acetate.
de Greef WJ; Dullaart J; Zeilmaker GH
J Endocrinol; 1976 Sep; 70(3):465-71. PubMed ID: 978105
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.
Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624
[TBL] [Abstract][Full Text] [Related]
7. Contraceptive steroid toxicology in the Beagle dog and its relevance to human carcinogenicity.
Owen LN; Briggs MH
Curr Med Res Opin; 1976; 4(5):309-29. PubMed ID: 64332
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Jeppsson S; Gershagen S; Johansson ED; Rannevik G
Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
10. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
Weikel JH; Nelson LW
J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic activity in women receiving an injectable progestogen for contraception.
Mishell DR; Kharma KM; Thorneycroft IH; Nakamura RM
Am J Obstet Gynecol; 1972 Jun; 113(3):372-6. PubMed ID: 4637029
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
Frick J; Bartsch G; Jakse G
Urol Res; 1977; 5(2):55-9. PubMed ID: 69351
[TBL] [Abstract][Full Text] [Related]
14. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
16. Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult beagle bitches.
Concannon PW; Spraker TR; Casey HW; Hansel W
Fertil Steril; 1981 Sep; 36(3):373-87. PubMed ID: 6456940
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of action of an antifertility vaccine in the rhesus monkey: reversal of the effects of antisera to the beta-subunit of ovine luteinizing hormone by medroxyprogesterone acetate.
Thau RB; Sundaram K
Fertil Steril; 1980 Mar; 33(3):317-20. PubMed ID: 6767627
[TBL] [Abstract][Full Text] [Related]
18. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
Rahimy MH; Ryan KK
Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
[TBL] [Abstract][Full Text] [Related]
19. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
Soufir JC; Jouannet P; Marson J; Soumah A
Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
[TBL] [Abstract][Full Text] [Related]
20. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. III. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depot-medroxyprogesterone acetate (DMPA).
Aedo AR; Landgren BM; Diczfalusy E
Contraception; 1981 Aug; 24(2):117-35. PubMed ID: 6457729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
